Capreomycin is a polypeptide antibiotic often classified alongside aminoglycosides, primarily utilized in combination therapy to treat multidrug-resistant tuberculosis. By binding to the bacterial 30S… Read more













Capreomycin is a polypeptide antibiotic often classified alongside aminoglycosides, primarily utilized in combination therapy to treat multidrug-resistant tuberculosis. By binding to the bacterial 30S ribosomal subunit, this drug effectively inhibits protein synthesis in susceptible pathogens. To ensure the safety and efficacy of therapeutic formulations, pharmaceutical laboratories rely on high-quality Capreomycin reference standards, including its various components and degradation products. This category contains a comprehensive selection of these compounds, which are essential for rigorous analytical testing and method validation. Researchers utilize these materials, including pharmacopeial and non-pharmacopeial impurities, to perform accurate impurity profiling and stability studies. Whether developing new manufacturing processes or conducting routine quality control, access to well-characterized Capreomycin standards and stable isotope labelled versions allows for precise quantification and compliance with regulatory standards throughout the drug development lifecycle.